Nuo Therapeutics Inc (OTCQX US:NUOT)

0.255
Delayed Data
As of May 26
 -0.005 / -1.92%
Today’s Change
0.14
Today|||52-Week Range
0.48
-27.14%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$32.7M

Company Description

Nuo Therapeutics, Inc. is a regenerative therapy company, developing and commercializing innovative autologous therapies that promote healing by harnessing the innate regenerative capacity of platelets and adult stem cells. It currently has a growing commercial operation, and a robust clinical pipeline seeking to exploit large market opportunities with unmet medical needs. The company's current commercial offerings are centered rich plasma platform technology, and primarily include the angel whole blood separation system and the autologel system. These products primarily address the areas of wound care, and support of healing and recovery following orthopedic procedures. The company was founded on April 29, 1998 and is headquartered in Gaithersburg, MD.

Contact Information

Nuo Therapeutics, Inc.
207A Perry Parkway
Gaithersburg Maryland 20877
P:(240) 499-2680
Investor Relations:

Employees

Shareholders

Individual stakeholders11.21%
Other institutional0.03%
Mutual fund holders0.00%

Top Executives

Martin P. RosendaleChief Executive Officer & Director
Patrick Paul VanekVice President-Operations
David Emerson JordenChief Financial Officer & Director
Peter A. ClausenChief Science Officer
Carelyn P. FyllingVice President-Professional Services

To view my watchlist

Not a member yet?

Sign up now for a free account